Affirm Journal of Therapeutics
Affirm Journal of Therapeutics is an international and peer-reviewed journal with an intercontinental advisory board. The journal documents the professional’s interest in any areas that connect to therapeutics. The focus of the journal is on theories and practice in complement therapeutics, experimental therapeutics, gene modification, drug development, and therapeutic applications. The editorial board of the Affirm Journal of Therapeutics invites authors to submit original papers, case studies and review papers to the journal. At Affirm Journal of Therapeutics, we expect the authors to abide Principles of Transparency and Best Practice in Scholarly Publishing suggested by The Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and Scopus.
Scope and Focus
Antisense Therapeutics
Aptamers
Cancer Therapeutics
Complement Therapeutics
Drug Development
Experimental Therapeutics
Gene Modification
Gene Therapeutics
Novel Therapeutics
Nucleic Acids Compounds
Polymer Therapeutics
Protein Therapeutics
Therapeutic Applications
Editor in chief
Dr. Loghman
Abstracting and Indexing
Google Scholar